| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.715 | 0.022 | 0.715 | Caspase 9 stimulant | 0.672 0.027 CID_6386 | ||
| 0.555 | 0.025 | 0.671 | Aldehyde oxidase inhibitor | 0.671 0.011 CID_6386 | CID_6386 | |
| 0.524 | 0.011 | 0.524 | Hypolipemic | 0.411 0.023 CID_6386 | ||
| 0.506 | 0.024 | 0.555 | GABA C receptor rho-3 antagonist | 0.555 0.014 CID_6386 | CID_6386 | |
| 0.503 | 0.032 | 0.555 | Cholesterol antagonist | 0.555 0.024 CID_6386 | CID_6386 | |
| 0.511 | 0.047 | 0.527 | Cyclophilin D inhibitor | 0.527 0.043 CID_6386 | CID_6386 | |
| 0.494 | 0.03 | 0.494 | Calcium channel L-type activator | 0.317 0.143 CID_6386 | ||
| 0.492 | 0.029 | 0.553 | 5 Hydroxytryptamine release stimulant | 0.553 0.02 CID_6386 | CID_6386 | |
| 0.467 | 0.004 | 0.507 | Tyrosine 3 hydroxylase inhibitor | 0.507 0.004 CID_6386 | CID_6386 | |
| 0.464 | 0.006 | 0.724 | Alpha-N-acetylglucosaminidase inhibitor | 0.724 0.003 CID_6386 | CID_6386 | |
| 0.487 | 0.037 | 0.53 | 5 Hydroxytryptamine release inhibitor | 0.53 0.024 CID_6386 | CID_6386 | |
| 0.456 | 0.01 | 0.456 | Calcium channel activator | 0.435 0.014 CID_6386 | ||
| 0.454 | 0.011 | 0.508 | Anesthetic general | 0.508 0.007 CID_6386 | CID_6386 | |
| 0.425 | 0.01 | 0.451 | 5 Hydroxytryptamine uptake stimulant | 0.451 0.007 CID_6386 | CID_6386 | |
| 0.464 | 0.053 | 0.494 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.494 0.036 CID_6386 | CID_6386 | |
| 0.407 | 0.02 | 0.545 | Peroxidase inhibitor | 0.545 0.006 CID_6386 | CID_6386 | |
| 0.408 | 0.026 | 0.408 | Tumour necrosis factor alpha release inhibitor | |||
| 0.353 | 0.021 | 0.353 | P-glycoprotein inhibitor | |||
| 0.39 | 0.066 | 0.39 | Transcription factor NF kappa B inhibitor | 0.297 0.096 CID_6386 | ||
| 0.333 | 0.015 | 0.354 | Gastrin inhibitor | 0.354 0.01 CID_6386 | CID_6386 | |
| 0.414 | 0.107 | 0.414 | Apoptosis agonist | |||
| 0.33 | 0.027 | 0.372 | RNA-directed DNA polymerase inhibitor | 0.372 0.021 CID_6386 | CID_6386 | |
| 0.42 | 0.127 | 0.42 | Antiinflammatory | |||
| 0.349 | 0.056 | 0.361 | Vasodilator, coronary | 0.361 0.05 CID_6386 | CID_6386 | |
| 0.361 | 0.069 | 0.432 | Vasodilator, peripheral | 0.432 0.046 CID_6386 | CID_6386 | |
| 0.377 | 0.087 | 0.49 | Histamine release inhibitor | 0.49 0.032 CID_6386 | CID_6386 | |
| 0.291 | 0.018 | 0.291 | Lck kinase inhibitor | |||
| 0.276 | 0.008 | 0.276 | GABA C receptor rho-2 antagonist | 0.249 0.012 CID_6386 | ||
| 0.28 | 0.017 | 0.288 | Nitric-oxide synthase stimulant | 0.288 0.014 CID_6386 | CID_6386 | |
| 0.306 | 0.045 | 0.418 | Interleukin agonist | 0.418 0.016 CID_6386 | CID_6386 | |
| 0.275 | 0.015 | 0.352 | Succinate dehydrogenase inhibitor | 0.352 0.005 CID_6386 | CID_6386 | |
| 0.295 | 0.037 | 0.295 | Platelet aggregation inhibitor | |||
| 0.265 | 0.011 | 0.427 | Ferrochelatase inhibitor | 0.427 0.003 CID_6386 | CID_6386 | |
| 0.302 | 0.05 | 0.389 | Superoxide dismutase inhibitor | 0.389 0.029 CID_6386 | CID_6386 | |
| 0.293 | 0.046 | 0.377 | DNA synthesis inhibitor | 0.377 0.025 CID_6386 | CID_6386 | |
| 0.254 | 0.008 | 0.254 | Calcium antagonist | 0.127 0.032 CID_6386 | ||
| 0.293 | 0.052 | 0.298 | Angiogenesis stimulant | 0.298 0.05 CID_6386 | CID_6386 | |
| 0.266 | 0.025 | 0.324 | Interferon gamma antagonist | 0.324 0.017 CID_6386 | CID_6386 | |
| 0.283 | 0.044 | 0.283 | Nitric oxide antagonist | 0.206 0.065 CID_6386 | ||
| 0.238 | 0.007 | 0.294 | GABA C receptor antagonist | 0.294 0.005 CID_6386 | CID_6386 | |
| 0.285 | 0.058 | 0.285 | Hypoglycemic | 0.253 0.075 CID_6386 | ||
| 0.236 | 0.01 | 0.238 | Catalase inhibitor | 0.238 0.01 CID_6386 | CID_6386 | |
| 0.244 | 0.019 | 0.244 | 5 Hydroxytryptamine 3E antagonist | 0.242 0.02 CID_6386 | ||
| 0.262 | 0.038 | 0.262 | Non-steroidal antiinflammatory agent | 0.232 0.051 CID_6386 | ||
| 0.236 | 0.012 | 0.236 | Microtubule formation inhibitor | 0.225 0.015 CID_6386 | ||
| 0.235 | 0.015 | 0.492 | GABA C receptor agonist | 0.492 0.004 CID_6386 | CID_6386 | |
| 0.221 | 0.003 | 0.221 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.242 | 0.027 | 0.264 | Phospholipase C inhibitor | 0.264 0.022 CID_6386 | CID_6386 | |
| 0.241 | 0.03 | 0.282 | Melanin inhibitor | 0.282 0.024 CID_6386 | CID_6386 | |
| 0.315 | 0.106 | 0.336 | Immunosuppressant | 0.336 0.094 CID_6386 | CID_6386 | |
| 0.213 | 0.006 | 0.573 | Alcohol oxidase inhibitor | 0.573 0.003 CID_6386 | CID_6386 | |
| 0.222 | 0.016 | 0.233 | Arachidonic acid antagonist | 0.233 0.01 CID_6386 | CID_6386 | |
| 0.236 | 0.03 | 0.239 | Lipid peroxidase inhibitor | 0.239 0.029 CID_6386 | CID_6386 | |
| 0.212 | 0.01 | 0.212 | Photosensitizer | 0.175 0.019 CID_6386 | ||
| 0.242 | 0.043 | 0.321 | Neurotrophic factor enhancer | 0.321 0.013 CID_6386 | CID_6386 | |
| 0.242 | 0.046 | 0.28 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.28 0.03 CID_6386 | CID_6386 | |
| 0.209 | 0.014 | 0.298 | Adenylate kinase inhibitor | 0.298 0.007 CID_6386 | CID_6386 | |
| 0.211 | 0.016 | 0.243 | CF transmembrane conductance regulator agonist | 0.243 0.007 CID_6386 | CID_6386 | |
| 0.201 | 0.008 | 0.219 | GABA C receptor rho-1 antagonist | 0.219 0.006 CID_6386 | CID_6386 | |
| 0.235 | 0.043 | 0.235 | Insulin sensitizer | 0.232 0.046 CID_6386 | ||
| 0.229 | 0.037 | 0.229 | 3C-like protease (Human coronavirus) inhibitor | 0.184 0.062 CID_6386 | ||
| 0.204 | 0.017 | 0.349 | UDP-glucose 4-epimerase inhibitor | 0.349 0.008 CID_6386 | CID_6386 | |
| 0.209 | 0.027 | 0.244 | Cell wall synthesis inhibitor | 0.244 0.017 CID_6386 | CID_6386 | |
| 0.187 | 0.005 | 0.204 | Ca2+-transporting ATPase inhibitor | 0.204 0.003 CID_6386 | CID_6386 | |
| 0.194 | 0.017 | 0.215 | Adenylate cyclase stimulant | 0.215 0.008 CID_6386 | CID_6386 | |
| 0.195 | 0.019 | 0.195 | Falcipain 3 inhibitor | 0.165 0.03 CID_6386 | ||
| 0.206 | 0.032 | 0.21 | ATPase inhibitor | 0.21 0.03 CID_6386 | CID_6386 | |
| 0.186 | 0.013 | 0.434 | Triose-phosphate isomerase inhibitor | 0.434 0.003 CID_6386 | CID_6386 | |
| 0.186 | 0.015 | 0.186 | Gastric antisecretory | 0.12 0.043 CID_6386 | ||
| 0.215 | 0.045 | 0.215 | Tumour necrosis factor antagonist | 0.157 0.092 CID_6386 | ||
| 0.184 | 0.015 | 0.245 | Histidine decarboxylase inhibitor | 0.245 0.009 CID_6386 | CID_6386 | |
| 0.189 | 0.02 | 0.189 | Beta amyloid protein antagonist | 0.153 0.038 CID_6386 | ||
| 0.188 | 0.024 | 0.188 | Nav1.6 sodium channel blocker | 0.163 0.041 CID_6386 | ||
| 0.246 | 0.082 | 0.246 | DNA damaging | 0.202 0.113 CID_6386 | ||
| 0.231 | 0.068 | 0.231 | Antimitotic | |||
| 0.235 | 0.072 | 0.242 | Cyclic AMP phosphodiesterase inhibitor | 0.242 0.068 CID_6386 | CID_6386 | |
| 0.167 | 0.005 | 0.23 | Glycine receptor agonist | 0.23 0.004 CID_6386 | CID_6386 | |
| 0.253 | 0.094 | 0.278 | Insulysin inhibitor | 0.278 0.073 CID_6386 | CID_6386 | |
| 0.17 | 0.013 | 0.17 | Electron transport complex I inhibitor | 0.163 0.015 CID_6386 | ||
| 0.163 | 0.006 | 0.163 | GABA aminotransferase inhibitor | 0.157 0.007 CID_6386 | ||
| 0.182 | 0.026 | 0.182 | Cyclooxygenase 3 inhibitor | 0.176 0.03 CID_6386 | ||
| 0.231 | 0.076 | 0.235 | Neuropeptide Y2 antagonist | 0.235 0.071 CID_6386 | CID_6386 | |
| 0.294 | 0.14 | 0.303 | Antibacterial | 0.303 0.133 CID_6386 | CID_6386 | |
| 0.183 | 0.029 | 0.215 | Cystathionine beta-synthase inhibitor | 0.215 0.021 CID_6386 | CID_6386 | |
| 0.188 | 0.035 | 0.188 | Calcium channel blocker | |||
| 0.167 | 0.014 | 0.264 | NADH dehydrogenase inhibitor | 0.264 0.007 CID_6386 | CID_6386 | |
| 0.183 | 0.031 | 0.183 | Platelet activating factor antagonist | |||
| 0.156 | 0.005 | 0.156 | Granulocyte macrophage colony stimulating factor agonist | 0.135 0.009 CID_6386 | ||
| 0.196 | 0.046 | 0.304 | Amylase inhibitor | 0.304 0.018 CID_6386 | CID_6386 | |
| 0.163 | 0.013 | 0.163 | Factor V inhibitor | 0.138 0.025 CID_6386 | ||
| 0.172 | 0.022 | 0.177 | Vanilloid 1 agonist | 0.177 0.019 CID_6386 | CID_6386 | |
| 0.237 | 0.088 | 0.237 | 5 Hydroxytryptamine 1E antagonist | 0.18 0.154 CID_6386 | ||
| 0.181 | 0.032 | 0.265 | Cholesterol synthesis inhibitor | 0.265 0.016 CID_6386 | CID_6386 | |
| 0.172 | 0.024 | 0.18 | Pregnane X receptor agonist | 0.18 0.018 CID_6386 | CID_6386 | |
| 0.231 | 0.083 | 0.231 | Calpain inhibitor | 0.186 0.127 CID_6386 | ||
| 0.197 | 0.051 | 0.197 | Antipruritic | 0.146 0.098 CID_6386 | ||
| 0.239 | 0.093 | 0.239 | Transcription factor STAT3 inhibitor | 0.233 0.099 CID_6386 | ||
| 0.185 | 0.039 | 0.204 | Mannose-6-phosphate isomerase inhibitor | 0.204 0.028 CID_6386 | CID_6386 | |
| 0.167 | 0.022 | 0.282 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.282 0.007 CID_6386 | CID_6386 | |
| 0.244 | 0.099 | 0.317 | Immunostimulant | 0.317 0.074 CID_6386 | CID_6386 | |
| 0.19 | 0.045 | 0.203 | Protein kinase stimulant | 0.203 0.04 CID_6386 | CID_6386 | |
| 0.16 | 0.017 | 0.175 | DOPA decarboxylase inhibitor | 0.175 0.012 CID_6386 | CID_6386 | |
| 0.167 | 0.024 | 0.181 | Sphingosine 1-phosphate receptor 2 antagonist | 0.181 0.015 CID_6386 | CID_6386 | |
| 0.159 | 0.016 | 0.296 | Phosphofructokinase-1 inhibitor | 0.296 0.005 CID_6386 | CID_6386 | |
| 0.26 | 0.118 | 0.315 | Antithrombotic | 0.315 0.079 CID_6386 | CID_6386 | |
| 0.163 | 0.024 | 0.227 | Antineoplastic alkaloid | 0.227 0.008 CID_6386 | CID_6386 | |
| 0.164 | 0.025 | 0.181 | Mucolytic | 0.181 0.018 CID_6386 | CID_6386 | |
| 0.15 | 0.011 | 0.314 | Argininosuccinate synthase inhibitor | 0.314 0.004 CID_6386 | CID_6386 | |
| 0.155 | 0.017 | 0.181 | Electrolyte absorption antagonist | 0.181 0.011 CID_6386 | CID_6386 | |
| 0.271 | 0.134 | 0.271 | Calpain 2 inhibitor | 0.199 0.189 CID_6386 | ||
| 0.149 | 0.012 | 0.149 | Glutamate (mGluR7) agonist | 0.12 0.03 CID_6386 | ||
| 0.145 | 0.011 | 0.145 | Glutamate release inhibitor | 0.131 0.016 CID_6386 | ||
| 0.142 | 0.007 | 0.142 | Elastase 1 inhibitor | |||
| 0.146 | 0.013 | 0.179 | Lanosterol 14 alpha demethylase inhibitor | 0.179 0.005 CID_6386 | CID_6386 | |
| 0.145 | 0.012 | 0.328 | Carbamoyl phosphate synthetase inhibitor | 0.328 0.004 CID_6386 | CID_6386 | |
| 0.151 | 0.018 | 0.177 | Anabolic | 0.177 0.008 CID_6386 | CID_6386 | |
| 0.137 | 0.004 | 0.154 | Glutamate (mGluR6) antagonist | 0.154 0.004 CID_6386 | CID_6386 | |
| 0.158 | 0.027 | 0.158 | Sphingosine 1-phosphate receptor 4 antagonist | 0.158 0.026 CID_6386 | ||
| 0.179 | 0.049 | 0.312 | Insulin secretagoues | 0.312 0.011 CID_6386 | CID_6386 | |
| 0.134 | 0.004 | 0.355 | Fumarate hydratase inhibitor | 0.355 0.002 CID_6386 | CID_6386 | |
| 0.155 | 0.028 | 0.165 | TRPA1 agonist | 0.165 0.022 CID_6386 | CID_6386 | |
| 0.164 | 0.039 | 0.164 | Proteasome inhibitor | 0.141 0.052 CID_6386 | ||
| 0.223 | 0.099 | 0.223 | Antioxidant | 0.219 0.102 CID_6386 | ||
| 0.128 | 0.005 | 0.128 | Ca(v)3.2 blocker | |||
| 0.188 | 0.065 | 0.285 | Lipocortins synthesis antagonist | 0.285 0.024 CID_6386 | CID_6386 | |
| 0.174 | 0.054 | 0.226 | Hexokinase inhibitor | 0.226 0.023 CID_6386 | CID_6386 | |
| 0.153 | 0.032 | 0.153 | Interleukin 8 antagonist | 0.15 0.034 CID_6386 | ||
| 0.142 | 0.022 | 0.142 | Acetylcholine release stimulant | 0.121 0.047 CID_6386 | ||
| 0.155 | 0.035 | 0.158 | Heat shock protein 70 antagonist | 0.158 0.031 CID_6386 | CID_6386 | |
| 0.146 | 0.026 | 0.246 | Creatine kinase inhibitor | 0.246 0.006 CID_6386 | CID_6386 | |
| 0.132 | 0.012 | 0.165 | Glycine receptor antagonist | 0.165 0.005 CID_6386 | CID_6386 | |
| 0.141 | 0.022 | 0.362 | Porphobilinogen synthase inhibitor | 0.362 0.004 CID_6386 | CID_6386 | |
| 0.13 | 0.011 | 0.205 | Acyl-CoA dehydrogenase inhibitor | 0.205 0.005 CID_6386 | CID_6386 | |
| 0.122 | 0.004 | 0.122 | Squalene epoxidase inhibitor | 0.084 0.009 CID_6386 | ||
| 0.121 | 0.005 | 0.121 | Potassium channel intermediate-conductance Ca-activated blocker | 0.068 0.028 CID_6386 | ||
| 0.16 | 0.046 | 0.192 | Sphingosine 1-phosphate receptor 5 antagonist | 0.192 0.015 CID_6386 | CID_6386 | |
| 0.172 | 0.059 | 0.184 | Neurotensin receptor agonist | 0.184 0.046 CID_6386 | CID_6386 | |
| 0.14 | 0.028 | 0.14 | Breast cancer-resistant protein inhibitor | |||
| 0.139 | 0.027 | 0.18 | Prolactin inhibitor | 0.18 0.013 CID_6386 | CID_6386 | |
| 0.159 | 0.047 | 0.162 | Toll-Like receptor 2 antagonist | 0.162 0.044 CID_6386 | CID_6386 | |
| 0.126 | 0.015 | 0.185 | Interferon agonist | 0.185 0.007 CID_6386 | CID_6386 | |
| 0.147 | 0.035 | 0.147 | Calcium channel (voltage-sensitive) blocker | |||
| 0.116 | 0.006 | 0.14 | Liver X receptor agonist | 0.14 0.005 CID_6386 | CID_6386 | |
| 0.143 | 0.033 | 0.143 | AMP-activated protein kinase stimulant | 0.134 0.039 CID_6386 | ||
| 0.114 | 0.005 | 0.114 | Exportin-1 inhibitor | 0.101 0.009 CID_6386 | ||
| 0.158 | 0.049 | 0.158 | NADPH oxidase inhibitor | 0.134 0.068 CID_6386 | ||
| 0.119 | 0.01 | 0.12 | Estrogen-related receptor beta agonist | 0.12 0.01 CID_6386 | CID_6386 | |
| 0.119 | 0.012 | 0.119 | Neuraminidase (influenza) inhibitor | 0.087 0.021 CID_6386 | ||
| 0.165 | 0.058 | 0.165 | Thiol protease inhibitor | 0.142 0.078 CID_6386 | ||
| 0.109 | 0.005 | 0.109 | Calcium channel P-type blocker | 0.089 0.009 CID_6386 | ||
| 0.139 | 0.035 | 0.156 | Carbonic anhydrase XV inhibitor | 0.156 0.028 CID_6386 | CID_6386 | |
| 0.125 | 0.021 | 0.319 | Glutamate dehydrogenase inhibitor | 0.319 0.005 CID_6386 | CID_6386 | |
| 0.141 | 0.039 | 0.162 | Expectorant | 0.162 0.031 CID_6386 | CID_6386 | |
| 0.187 | 0.088 | 0.245 | Psychostimulant | 0.245 0.06 CID_6386 | CID_6386 | |
| 0.119 | 0.02 | 0.142 | Peroxisome proliferator-activated receptor gamma agonist | 0.142 0.014 CID_6386 | CID_6386 | |
| 0.12 | 0.022 | 0.197 | Keratolytic | 0.197 0.009 CID_6386 | CID_6386 | |
| 0.146 | 0.049 | 0.146 | Alkylator | 0.14 0.052 CID_6386 | ||
| 0.11 | 0.013 | 0.11 | Secretase beta inhibitor | 0.083 0.033 CID_6386 | ||
| 0.162 | 0.067 | 0.162 | Cytidine deaminase inhibitor | 0.133 0.088 CID_6386 | ||
| 0.114 | 0.018 | 0.114 | Calcium channel L-type blocker | 0.074 0.047 CID_6386 | ||
| 0.106 | 0.01 | 0.138 | Interferon inducer | 0.138 0.005 CID_6386 | CID_6386 | |
| 0.103 | 0.008 | 0.227 | Aconitate hydratase inhibitor | 0.227 0.003 CID_6386 | CID_6386 | |
| 0.173 | 0.079 | 0.203 | MAP kinase kinase 5 inhibitor | 0.203 0.03 CID_6386 | CID_6386 | |
| 0.117 | 0.025 | 0.117 | Bromodomain-containing protein 2 inhibitor | 0.099 0.041 CID_6386 | ||
| 0.108 | 0.016 | 0.22 | Biliverdin reductase inhibitor | 0.22 0.005 CID_6386 | CID_6386 | |
| 0.096 | 0.005 | 0.096 | Glutamate (mGluR1a) antagonist | 0.084 0.008 CID_6386 | ||
| 0.098 | 0.006 | 0.098 | Renin inhibitor | |||
| 0.097 | 0.006 | 0.097 | Secretase gamma inhibitor | |||
| 0.171 | 0.08 | 0.171 | Amyloid beta precursor protein antagonist | |||
| 0.127 | 0.036 | 0.141 | Sphingomyelinase inhibitor | 0.141 0.029 CID_6386 | CID_6386 | |
| 0.152 | 0.062 | 0.152 | Neuropeptide Y1 antagonist | |||
| 0.096 | 0.007 | 0.113 | Alpha-mannosidase inhibitor | 0.113 0.005 CID_6386 | CID_6386 | |
| 0.146 | 0.057 | 0.146 | Sodium channel (voltage-gated) blocker | |||
| 0.111 | 0.023 | 0.111 | mTOR complex 2 inhibitor | 0.108 0.025 CID_6386 | ||
| 0.1 | 0.014 | 0.173 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.173 0.008 CID_6386 | CID_6386 | |
| 0.101 | 0.015 | 0.101 | Protease 3C (Human rhinovirus) inhibitor | 0.09 0.021 CID_6386 | ||
| 0.162 | 0.076 | 0.162 | Src kinase inhibitor | |||
| 0.109 | 0.024 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.115 0.02 CID_6386 | CID_6386 | |
| 0.209 | 0.125 | 0.215 | Transcription factor STAT inhibitor | 0.215 0.118 CID_6386 | CID_6386 | |
| 0.102 | 0.019 | 0.102 | Acetylcholine M5 receptor agonist | 0.072 0.042 CID_6386 | ||
| 0.123 | 0.04 | 0.123 | Toll-Like receptor 4 antagonist | |||
| 0.138 | 0.056 | 0.154 | Cathepsin H inhibitor | 0.154 0.043 CID_6386 | CID_6386 | |
| 0.138 | 0.055 | 0.138 | Anesthetic local | 0.134 0.057 CID_6386 | ||
| 0.175 | 0.094 | 0.192 | I kappa B kinase epsilon inhibitor | 0.192 0.078 CID_6386 | CID_6386 | |
| 0.098 | 0.016 | 0.098 | Neuraminidase inhibitor | 0.077 0.028 CID_6386 | ||
| 0.086 | 0.005 | 0.086 | Pregnane X receptor antagonist | 0.086 0.005 CID_6386 | ||
| 0.097 | 0.016 | 0.104 | MAP kinase kinase 7 inhibitor | 0.104 0.01 CID_6386 | CID_6386 | |
| 0.097 | 0.018 | 0.109 | NMDA receptor glycine site agonist | 0.109 0.012 CID_6386 | CID_6386 | |
| 0.086 | 0.007 | 0.146 | Glucose-6-phosphate isomerase inhibitor | 0.146 0.003 CID_6386 | CID_6386 | |
| 0.199 | 0.12 | 0.286 | Spasmolytic | 0.286 0.076 CID_6386 | CID_6386 | |
| 0.085 | 0.006 | 0.088 | Adenylate cyclase 1 inhibitor | 0.088 0.005 CID_6386 | CID_6386 | |
| 0.168 | 0.09 | 0.168 | Platelet adhesion inhibitor | |||
| 0.093 | 0.015 | 0.099 | Glutamate (mGluR7) antagonist | 0.099 0.011 CID_6386 | CID_6386 | |
| 0.135 | 0.058 | 0.177 | Aldehyde dehydrogenase inhibitor | 0.177 0.035 CID_6386 | CID_6386 | |
| 0.111 | 0.033 | 0.124 | Ornithine decarboxylase inhibitor | 0.124 0.023 CID_6386 | CID_6386 | |
| 0.082 | 0.005 | 0.089 | Cytokine production stimulant | 0.089 0.004 CID_6386 | CID_6386 | |
| 0.092 | 0.016 | 0.092 | Cathepsin E inhibitor | 0.058 0.043 CID_6386 | ||
| 0.091 | 0.015 | 0.091 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 CID_6386 | ||
| 0.175 | 0.099 | 0.207 | MAP kinase kinase 2 inhibitor | 0.207 0.078 CID_6386 | CID_6386 | |
| 0.099 | 0.023 | 0.1 | CC chemokine 5 receptor agonist | 0.1 0.022 CID_6386 | CID_6386 | |
| 0.093 | 0.018 | 0.129 | Androgen agonist | 0.129 0.009 CID_6386 | CID_6386 | |
| 0.083 | 0.008 | 0.083 | Ryanodine receptor antagonist | 0.074 0.013 CID_6386 | ||
| 0.112 | 0.038 | 0.183 | Androgen antagonist | 0.183 0.015 CID_6386 | CID_6386 | |
| 0.124 | 0.05 | 0.194 | Aminopeptidase B inhibitor | 0.194 0.023 CID_6386 | CID_6386 | |
| 0.106 | 0.032 | 0.106 | Glutathione S-transferase inhibitor | 0.102 0.035 CID_6386 | ||
| 0.119 | 0.045 | 0.137 | Carbonic anhydrase III inhibitor | 0.137 0.034 CID_6386 | CID_6386 | |
| 0.102 | 0.029 | 0.189 | Glutamate decarboxylase inhibitor | 0.189 0.008 CID_6386 | CID_6386 | |
| 0.093 | 0.021 | 0.093 | Cathepsin D inhibitor | |||
| 0.187 | 0.115 | 0.187 | Vasodilator | |||
| 0.077 | 0.005 | 0.077 | DNA gyrase subunit A inhibitor | |||
| 0.086 | 0.014 | 0.101 | MDM2 inhibitor | 0.101 0.006 CID_6386 | CID_6386 | |
| 0.104 | 0.033 | 0.104 | Macrophage migration inhibitory factor inhibitor | 0.085 0.046 CID_6386 | ||
| 0.124 | 0.053 | 0.124 | GABA receptor agonist | 0.107 0.069 CID_6386 | ||
| 0.102 | 0.033 | 0.102 | Myeloperoxidase inhibitor | 0.086 0.056 CID_6386 | ||
| 0.082 | 0.012 | 0.082 | Kallikrein 7 inhibitor | |||
| 0.092 | 0.023 | 0.141 | GABA B receptor agonist | 0.141 0.005 CID_6386 | CID_6386 | |
| 0.081 | 0.012 | 0.081 | Leukocyte elastase inhibitor | 0.048 0.025 CID_6386 | ||
| 0.077 | 0.009 | 0.098 | Mannosidase inhibitor | 0.098 0.006 CID_6386 | CID_6386 | |
| 0.129 | 0.062 | 0.232 | Papain-like protease (SARS coronavirus) inhibitor | 0.232 0.006 CID_6386 | CID_6386 | |
| 0.146 | 0.079 | 0.161 | Phospholipase A2 inhibitor | 0.161 0.065 CID_6386 | CID_6386 | |
| 0.111 | 0.045 | 0.173 | HIV-1 integrase (Overall Integration) inhibitor | 0.173 0.018 CID_6386 | CID_6386 | |
| 0.089 | 0.024 | 0.097 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.097 0.016 CID_6386 | CID_6386 | |
| 0.12 | 0.056 | 0.122 | 5 Hydroxytryptamine 3A agonist | 0.122 0.054 CID_6386 | CID_6386 | |
| 0.115 | 0.052 | 0.13 | Protease inhibitor | 0.13 0.041 CID_6386 | CID_6386 | |
| 0.085 | 0.022 | 0.133 | Purinergic P2X1 antagonist | 0.133 0.009 CID_6386 | CID_6386 | |
| 0.14 | 0.077 | 0.14 | MAP3K9 inhibitor | |||
| 0.094 | 0.031 | 0.156 | Aminopeptidase I inhibitor | 0.156 0.012 CID_6386 | CID_6386 | |
| 0.079 | 0.017 | 0.079 | Elastase inhibitor | |||
| 0.172 | 0.11 | 0.172 | Histone acetyltransferase inhibitor | 0.169 0.115 CID_6386 | ||
| 0.085 | 0.024 | 0.107 | Potassium channel (ATP-sensitive) blocker | 0.107 0.013 CID_6386 | CID_6386 | |
| 0.1 | 0.038 | 0.13 | Carbonic anhydrase XIII inhibitor | 0.13 0.026 CID_6386 | CID_6386 | |
| 0.103 | 0.043 | 0.128 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.128 0.031 CID_6386 | CID_6386 | |
| 0.124 | 0.064 | 0.124 | DNA repair enzyme inhibitor | 0.12 0.073 CID_6386 | ||
| 0.066 | 0.007 | 0.068 | Guanylate cyclase inhibitor | 0.068 0.005 CID_6386 | CID_6386 | |
| 0.084 | 0.025 | 0.084 | Potassium channel (Tandem pore domain) blocker | 0.083 0.027 CID_6386 | ||
| 0.078 | 0.019 | 0.081 | Transcription factor RelA inhibitor | 0.081 0.016 CID_6386 | CID_6386 | |
| 0.107 | 0.048 | 0.126 | MAP kinase kinase 1 inhibitor | 0.126 0.029 CID_6386 | CID_6386 | |
| 0.061 | 0.003 | 0.061 | Elastase 3B inhibitor | 0.033 0.016 CID_6386 | ||
| 0.061 | 0.003 | 0.061 | Elastase 2B inhibitor | 0.033 0.016 CID_6386 | ||
| 0.061 | 0.003 | 0.061 | Elastase 3A inhibitor | 0.033 0.016 CID_6386 | ||
| 0.098 | 0.04 | 0.098 | GABA A receptor agonist | 0.077 0.069 CID_6386 | ||
| 0.164 | 0.106 | 0.164 | DNA methylase inhibitor | 0.149 0.118 CID_6386 | ||
| 0.094 | 0.037 | 0.113 | D-Ala-D-Ala ligase inhibitor | 0.113 0.017 CID_6386 | CID_6386 | |
| 0.062 | 0.005 | 0.062 | Methionyl aminopeptidase 1 inhibitor | 0.037 0.015 CID_6386 | ||
| 0.087 | 0.029 | 0.107 | Vanilloid 4 agonist | 0.107 0.012 CID_6386 | CID_6386 | |
| 0.134 | 0.076 | 0.134 | Cytokine production inhibitor | 0.112 0.098 CID_6386 | ||
| 0.089 | 0.032 | 0.293 | Phenylalanine 4-hydroxylase inhibitor | 0.293 0.004 CID_6386 | CID_6386 | |
| 0.071 | 0.015 | 0.071 | Potassium channel Kv1.3 blocker | 0.053 0.027 CID_6386 | ||
| 0.118 | 0.062 | 0.123 | Caspase 3 inhibitor | 0.123 0.056 CID_6386 | CID_6386 | |
| 0.068 | 0.013 | 0.082 | Potassium channel (Inward rectifier) activator | 0.082 0.007 CID_6386 | CID_6386 | |
| 0.119 | 0.064 | 0.119 | Calcium channel N-type blocker | |||
| 0.069 | 0.015 | 0.144 | Mineralocorticoid receptor antagonist | 0.144 0.005 CID_6386 | CID_6386 | |
| 0.069 | 0.015 | 0.069 | HCV NS3/NS4A protease inhibitor | 0.06 0.021 CID_6386 | ||
| 0.087 | 0.034 | 0.087 | Benzodiazepine agonist | |||
| 0.087 | 0.034 | 0.087 | Prostaglandin-E synthase inhibitor | 0.079 0.04 CID_6386 | ||
| 0.065 | 0.013 | 0.065 | Cholesterol esterase inhibitor | 0.053 0.026 CID_6386 | ||
| 0.065 | 0.012 | 0.079 | Potassium channel (ATP-sensitive) activator | 0.079 0.007 CID_6386 | CID_6386 | |
| 0.101 | 0.049 | 0.121 | Phosphodiesterase 6D inhibitor | 0.121 0.024 CID_6386 | CID_6386 | |
| 0.076 | 0.024 | 0.076 | Calcium channel T-type blocker | |||
| 0.072 | 0.02 | 0.142 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.142 0.005 CID_6386 | CID_6386 | |
| 0.079 | 0.028 | 0.079 | Aryl hydrocarbon receptor antagonist | 0.079 0.028 CID_6386 | ||
| 0.089 | 0.038 | 0.089 | Cathepsin G inhibitor | 0.081 0.043 CID_6386 | ||
| 0.152 | 0.102 | 0.152 | DNA methyltransferase I inhibitor | 0.147 0.107 CID_6386 | ||
| 0.079 | 0.029 | 0.114 | NMDA receptor agonist | 0.114 0.015 CID_6386 | CID_6386 | |
| 0.062 | 0.012 | 0.062 | Microtubule stabilization | 0.058 0.017 CID_6386 | ||
| 0.127 | 0.077 | 0.127 | Sodium channel blocker | |||
| 0.062 | 0.013 | 0.066 | AICAR transformylase inhibitor | 0.066 0.011 CID_6386 | CID_6386 | |
| 0.081 | 0.033 | 0.081 | Nav1.7 sodium channel blocker | |||
| 0.061 | 0.013 | 0.075 | Geranyltranstransferase inhibitor | 0.075 0.006 CID_6386 | CID_6386 | |
| 0.081 | 0.033 | 0.082 | Peroxisome proliferator-activated receptor gamma antagonist | 0.082 0.031 CID_6386 | CID_6386 | |
| 0.061 | 0.012 | 0.072 | Liver X receptor alpha agonist | 0.072 0.008 CID_6386 | CID_6386 | |
| 0.067 | 0.019 | 0.073 | Nicotinic alpha3beta2 receptor antagonist | 0.073 0.016 CID_6386 | CID_6386 | |
| 0.083 | 0.036 | 0.083 | MAP3K7 inhibitor | |||
| 0.11 | 0.063 | 0.11 | Protein kinase C gamma inhibitor | 0.105 0.068 CID_6386 | ||
| 0.055 | 0.009 | 0.079 | Kainate receptor agonist | 0.079 0.004 CID_6386 | CID_6386 | |
| 0.053 | 0.007 | 0.053 | Liver X receptor beta antagonist | 0.051 0.008 CID_6386 | ||
| 0.055 | 0.009 | 0.072 | Liver X receptor beta agonist | 0.072 0.007 CID_6386 | CID_6386 | |
| 0.061 | 0.017 | 0.061 | Fructose-1,6-bisphosphatase inhibitor | 0.061 0.017 CID_6386 | ||
| 0.062 | 0.018 | 0.073 | Aldosterone antagonist | 0.073 0.013 CID_6386 | CID_6386 | |
| 0.067 | 0.023 | 0.067 | Peroxisome proliferator-activated receptor alpha agonist | 0.058 0.027 CID_6386 | ||
| 0.087 | 0.043 | 0.087 | CYP2A6 inhibitor | 0.083 0.046 CID_6386 | ||
| 0.063 | 0.02 | 0.087 | Topoisomerase II beta inhibitor | 0.087 0.012 CID_6386 | CID_6386 | |
| 0.097 | 0.055 | 0.155 | ABCA1 expression enhancer | 0.155 0.016 CID_6386 | CID_6386 | |
| 0.056 | 0.014 | 0.056 | G protein-coupled receptor agonist | 0.046 0.02 CID_6386 | ||
| 0.049 | 0.008 | 0.049 | Cholesterol ester transfer protein antagonist | 0.048 0.008 CID_6386 | ||
| 0.051 | 0.01 | 0.051 | Peptide deformylase inhibitor | 0.04 0.014 CID_6386 | ||
| 0.05 | 0.009 | 0.05 | Vanilloid 3 antagonist | 0.048 0.01 CID_6386 | ||
| 0.079 | 0.039 | 0.088 | HIV-1 integrase inhibitor | 0.088 0.032 CID_6386 | CID_6386 | |
| 0.087 | 0.046 | 0.087 | Chymotrypsin inhibitor | |||
| 0.066 | 0.025 | 0.083 | Sphingosine kinase 2 inhibitor | 0.083 0.014 CID_6386 | CID_6386 | |
| 0.054 | 0.014 | 0.057 | Alpha 1d adrenoreceptor agonist | 0.057 0.012 CID_6386 | CID_6386 | |
| 0.064 | 0.024 | 0.064 | Epithelial sodium channel blocker | 0.057 0.033 CID_6386 | ||
| 0.071 | 0.031 | 0.087 | Carbonic anhydrase stimulant | 0.087 0.023 CID_6386 | CID_6386 | |
| 0.052 | 0.013 | 0.076 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.076 0.004 CID_6386 | CID_6386 | |
| 0.047 | 0.007 | 0.047 | Epoxide hydrolase 1 inhibitor | 0.035 0.016 CID_6386 | ||
| 0.061 | 0.022 | 0.066 | Immunoglobulin Fc receptor antagonist | 0.066 0.015 CID_6386 | CID_6386 | |
| 0.07 | 0.031 | 0.07 | Glutamate (mGluR1) antagonist | 0.058 0.041 CID_6386 | ||
| 0.05 | 0.011 | 0.07 | Glutamate (mGluR8) agonist | 0.07 0.005 CID_6386 | CID_6386 | |
| 0.049 | 0.011 | 0.049 | Glucose-dependent insulinotropic receptor agonist | 0.033 0.026 CID_6386 | ||
| 0.044 | 0.006 | 0.044 | Calcium-independent phospholipase A2 inhibitor | 0.037 0.015 CID_6386 | ||
| 0.06 | 0.022 | 0.073 | Lysophosphatidic acid 3 receptor antagonist | 0.073 0.012 CID_6386 | CID_6386 | |
| 0.068 | 0.031 | 0.068 | Cyclin D1 inhibitor | 0.055 0.052 CID_6386 | ||
| 0.068 | 0.031 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.051 CID_6386 | ||
| 0.051 | 0.014 | 0.081 | Phosphoglycerate kinase inhibitor | 0.081 0.008 CID_6386 | CID_6386 | |
| 0.088 | 0.052 | 0.088 | Antineoplastic antibiotic | 0.074 0.062 CID_6386 | ||
| 0.041 | 0.004 | 0.041 | Hedgehog signaling activator | 0.041 0.004 CID_6386 | ||
| 0.085 | 0.05 | 0.085 | Caspase 7 inhibitor | |||
| 0.051 | 0.016 | 0.051 | Angiotensin AT1 receptor antagonist | 0.05 0.018 CID_6386 | ||
| 0.06 | 0.025 | 0.06 | Carbonic anhydrase XIV inhibitor | 0.044 0.04 CID_6386 | ||
| 0.038 | 0.003 | 0.038 | Carbonic anhydrase VIII inhibitor | 0.033 0.004 CID_6386 | ||
| 0.038 | 0.003 | 0.038 | Carbonic anhydrase X inhibitor | 0.033 0.004 CID_6386 | ||
| 0.069 | 0.035 | 0.069 | Cannabinoid CB1 receptor antagonist | |||
| 0.057 | 0.023 | 0.072 | Adenosine deaminase inhibitor | 0.072 0.013 CID_6386 | CID_6386 | |
| 0.059 | 0.026 | 0.059 | H+/K+-transporting ATPase inhibitor | |||
| 0.052 | 0.018 | 0.052 | GABA B receptor antagonist | 0.049 0.02 CID_6386 | ||
| 0.051 | 0.017 | 0.077 | Dopamine D5 agonist | 0.077 0.007 CID_6386 | CID_6386 | |
| 0.055 | 0.021 | 0.06 | CC chemokine 4 receptor antagonist | 0.06 0.016 CID_6386 | CID_6386 | |
| 0.059 | 0.026 | 0.059 | Prolyl endopeptidase inhibitor | 0.05 0.036 CID_6386 | ||
| 0.091 | 0.058 | 0.132 | Potassium channel activator | 0.132 0.026 CID_6386 | CID_6386 | |
| 0.063 | 0.03 | 0.124 | Ornithine carbamoyltransferase inhibitor | 0.124 0.012 CID_6386 | CID_6386 | |
| 0.038 | 0.006 | 0.039 | Lysophosphatidic acid receptor 1 agonist | 0.039 0.006 CID_6386 | CID_6386 | |
| 0.193 | 0.161 | 0.193 | Hypoxia-inducible factor 1 alpha inhibitor | 0.192 0.161 CID_6386 | ||
| 0.048 | 0.017 | 0.082 | Membrane dipeptidase inhibitor | 0.082 0.005 CID_6386 | CID_6386 | |
| 0.063 | 0.032 | 0.063 | Acetylcholine muscarinic agonist | |||
| 0.075 | 0.044 | 0.098 | Phospholipase D inhibitor | 0.098 0.016 CID_6386 | CID_6386 | |
| 0.057 | 0.026 | 0.083 | Potassium channel (Inward rectifier) blocker | 0.083 0.012 CID_6386 | CID_6386 | |
| 0.049 | 0.019 | 0.056 | Nerve growth factor antagonist | 0.056 0.012 CID_6386 | CID_6386 | |
| 0.093 | 0.063 | 0.099 | Potassium channel (Voltage-sensitive) activator | 0.099 0.055 CID_6386 | CID_6386 | |
| 0.036 | 0.006 | 0.045 | Prostaglandin F2 alpha agonist | 0.045 0.005 CID_6386 | CID_6386 | |
| 0.038 | 0.008 | 0.044 | Purinergic P2Y15 antagonist | 0.044 0.005 CID_6386 | CID_6386 | |
| 0.103 | 0.074 | 0.148 | Monophenol monooxygenase inhibitor | 0.148 0.048 CID_6386 | CID_6386 | |
| 0.042 | 0.012 | 0.042 | Melatonin receptor 1A agonist | 0.031 0.029 CID_6386 | ||
| 0.059 | 0.03 | 0.059 | Cannabinoid CB2 receptor antagonist | 0.046 0.04 CID_6386 | ||
| 0.035 | 0.008 | 0.035 | Elastase 2 inhibitor | |||
| 0.035 | 0.008 | 0.035 | Elastase 2A inhibitor | |||
| 0.031 | 0.004 | 0.031 | Lysophosphatidic acid receptor 3 agonist | 0.027 0.004 CID_6386 | ||
| 0.04 | 0.014 | 0.04 | Liver X receptor antagonist | 0.038 0.015 CID_6386 | ||
| 0.034 | 0.007 | 0.034 | Glucosylceramidase stimulant | |||
| 0.045 | 0.019 | 0.075 | Arginase inhibitor | 0.075 0.006 CID_6386 | CID_6386 | |
| 0.034 | 0.009 | 0.046 | Nicotinic acid receptor 2 antagonist | 0.046 0.004 CID_6386 | CID_6386 | |
| 0.084 | 0.059 | 0.084 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.063 | 0.038 | 0.063 | Collagenase 3 inhibitor | 0.059 0.042 CID_6386 | ||
| 0.085 | 0.061 | 0.1 | Histamine N-methyltransferase inhibitor | 0.1 0.046 CID_6386 | CID_6386 | |
| 0.081 | 0.056 | 0.092 | Carbonic anhydrase VI inhibitor | 0.092 0.044 CID_6386 | CID_6386 | |
| 0.036 | 0.012 | 0.036 | Liver X receptor alpha antagonist | 0.032 0.016 CID_6386 | ||
| 0.045 | 0.022 | 0.045 | Plasmepsin II inhibitor | |||
| 0.044 | 0.021 | 0.076 | GABA uptake inhibitor | 0.076 0.005 CID_6386 | CID_6386 | |
| 0.045 | 0.023 | 0.058 | Thymidine kinase inhibitor | 0.058 0.014 CID_6386 | CID_6386 | |
| 0.076 | 0.054 | 0.078 | Nicotinic alpha4beta2 receptor antagonist | 0.078 0.053 CID_6386 | CID_6386 | |
| 0.063 | 0.041 | 0.063 | Histone deacetylase SIRT3 inhibitor | 0.059 0.051 CID_6386 | ||
| 0.049 | 0.027 | 0.049 | Purinergic P2X4 antagonist | 0.043 0.037 CID_6386 | ||
| 0.064 | 0.042 | 0.074 | 5 Hydroxytryptamine 3 agonist | 0.074 0.032 CID_6386 | CID_6386 | |
| 0.029 | 0.008 | 0.029 | 5 Hydroxytryptamine 4 agonist | 0.024 0.017 CID_6386 | ||
| 0.07 | 0.049 | 0.07 | Cannabinoid receptor antagonist | |||
| 0.091 | 0.07 | 0.104 | Bile acid receptor antagonist | 0.104 0.042 CID_6386 | CID_6386 | |
| 0.102 | 0.081 | 0.102 | Nav1.5 sodium channel blocker | |||
| 0.052 | 0.031 | 0.063 | CD45 antagonist | 0.063 0.019 CID_6386 | CID_6386 | |
| 0.2 | 0.179 | 0.2 | Apoptosis antagonist | |||
| 0.029 | 0.009 | 0.029 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.029 0.008 CID_6386 | ||
| 0.025 | 0.005 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.005 CID_6386 | CID_6386 | |
| 0.03 | 0.01 | 0.039 | Vanilloid 2 agonist | 0.039 0.004 CID_6386 | CID_6386 | |
| 0.074 | 0.053 | 0.074 | Phosphodiesterase VI inhibitor | 0.074 0.053 CID_6386 | ||
| 0.046 | 0.027 | 0.046 | Cholecystokinin antagonist | |||
| 0.056 | 0.036 | 0.083 | Dihydroorotate oxidase inhibitor | 0.083 0.009 CID_6386 | CID_6386 | |
| 0.037 | 0.018 | 0.037 | Angiotensin II receptor antagonist | 0.036 0.02 CID_6386 | ||
| 0.059 | 0.04 | 0.085 | Sphingosine kinase inhibitor | 0.085 0.013 CID_6386 | CID_6386 | |
| 0.024 | 0.005 | 0.033 | Telomerase stimulant | 0.033 0.003 CID_6386 | CID_6386 | |
| 0.054 | 0.036 | 0.054 | GABA A receptor antagonist | |||
| 0.047 | 0.028 | 0.106 | Parathyroid hormone antagonist | 0.106 0.003 CID_6386 | CID_6386 | |
| 0.031 | 0.013 | 0.031 | HCV NS5A inhibitor | |||
| 0.045 | 0.027 | 0.05 | HIV-1 protease inhibitor | 0.05 0.021 CID_6386 | CID_6386 | |
| 0.046 | 0.027 | 0.055 | Glutamate (mGluR group III) antagonist | 0.055 0.016 CID_6386 | CID_6386 | |
| 0.031 | 0.013 | 0.031 | Calcium-sensing receptor agonist | 0.03 0.013 CID_6386 | ||
| 0.055 | 0.037 | 0.055 | GABA receptor antagonist | |||
| 0.035 | 0.017 | 0.046 | Glutamate (mGluR3) agonist | 0.046 0.006 CID_6386 | CID_6386 | |
| 0.025 | 0.007 | 0.025 | Factor XIII inhibitor | 0.02 0.016 CID_6386 | ||
| 0.058 | 0.04 | 0.067 | Lipocortins synthesis agonist | 0.067 0.024 CID_6386 | CID_6386 | |
| 0.069 | 0.051 | 0.069 | Protein kinase C beta inhibitor | 0.069 0.05 CID_6386 | ||
| 0.18 | 0.163 | 0.18 | Lipoxygenase inhibitor | |||
| 0.049 | 0.032 | 0.057 | Dopamine beta hydroxylase inhibitor | 0.057 0.019 CID_6386 | CID_6386 | |
| 0.039 | 0.022 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.038 0.023 CID_6386 | ||
| 0.039 | 0.022 | 0.046 | Integrin alpha2 antagonist | 0.046 0.014 CID_6386 | CID_6386 | |
| 0.045 | 0.028 | 0.045 | Acetylcholine M1 receptor agonist | |||
| 0.04 | 0.023 | 0.048 | Potassium channel Kv1.1 blocker | 0.048 0.014 CID_6386 | CID_6386 | |
| 0.091 | 0.075 | 0.091 | MAP kinase kinase kinase inhibitor | |||
| 0.034 | 0.018 | 0.043 | Prostaglandin agonist | 0.043 0.012 CID_6386 | CID_6386 | |
| 0.079 | 0.064 | 0.083 | Inducible nitric-oxide synthase inhibitor | 0.083 0.057 CID_6386 | CID_6386 | |
| 0.023 | 0.008 | 0.028 | Toll-Like receptor 8 agonist | 0.028 0.005 CID_6386 | CID_6386 | |
| 0.073 | 0.058 | 0.091 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.091 0.043 CID_6386 | CID_6386 | |
| 0.018 | 0.004 | 0.018 | Glucose-dependent insulinotropic receptor antagonist | |||
| 0.025 | 0.011 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 CID_6386 | CID_6386 | |
| 0.024 | 0.01 | 0.037 | Neuraminidase (Influenza B) inhibitor | 0.037 0.004 CID_6386 | CID_6386 | |
| 0.031 | 0.017 | 0.042 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.042 0.011 CID_6386 | CID_6386 | |
| 0.028 | 0.015 | 0.044 | Methionyl aminopeptidase 2 inhibitor | 0.044 0.008 CID_6386 | CID_6386 | |
| 0.037 | 0.024 | 0.07 | Retinoid X receptor agonist | 0.07 0.01 CID_6386 | CID_6386 | |
| 0.047 | 0.034 | 0.047 | Benzodiazepine antagonist | |||
| 0.03 | 0.017 | 0.04 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.04 0.011 CID_6386 | CID_6386 | |
| 0.07 | 0.058 | 0.07 | Adenosine A3 receptor antagonist | |||
| 0.032 | 0.019 | 0.032 | Plasmepsin I inhibitor | |||
| 0.11 | 0.098 | 0.13 | Antibacterial (Helicobacter pylori) | 0.13 0.067 CID_6386 | CID_6386 | |
| 0.057 | 0.045 | 0.06 | Heat shock protein 90 beta antagonist | 0.06 0.039 CID_6386 | CID_6386 | |
| 0.137 | 0.124 | 0.205 | Hepatoprotectant | 0.205 0.062 CID_6386 | CID_6386 | |
| 0.017 | 0.005 | 0.017 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.028 | 0.016 | 0.034 | Integrin alpha2beta1 antagonist | 0.034 0.009 CID_6386 | CID_6386 | |
| 0.027 | 0.015 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 CID_6386 | CID_6386 | |
| 0.021 | 0.009 | 0.021 | Ileal bile acid transport inhibitor | 0.019 0.009 CID_6386 | ||
| 0.031 | 0.019 | 0.031 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.026 | 0.014 | 0.036 | Glutamate (mGluR1) agonist | 0.036 0.006 CID_6386 | CID_6386 | |
| 0.021 | 0.01 | 0.021 | Cyclin T1 inhibitor | |||
| 0.042 | 0.031 | 0.044 | Histamine H2 receptor agonist | 0.044 0.029 CID_6386 | CID_6386 | |
| 0.02 | 0.009 | 0.069 | Potassium channel (Inward rectifier) 11 blocker | 0.069 0.002 CID_6386 | CID_6386 | |
| 0.027 | 0.016 | 0.037 | Sodium/glucose cotransporter 2 inhibitor | 0.037 0.009 CID_6386 | CID_6386 | |
| 0.04 | 0.029 | 0.047 | Toll-Like receptor 2 agonist | 0.047 0.025 CID_6386 | CID_6386 | |
| 0.037 | 0.026 | 0.037 | Cholecystokinin A antagonist | |||
| 0.029 | 0.019 | 0.05 | Uridine phosphorylase inhibitor | 0.05 0.008 CID_6386 | CID_6386 | |
| 0.026 | 0.016 | 0.026 | Complement factor 1s inhibitor | 0.025 0.018 CID_6386 | ||
| 0.029 | 0.019 | 0.029 | MAP3K8 inhibitor | 0.029 0.021 CID_6386 | ||
| 0.019 | 0.01 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.004 CID_6386 | CID_6386 | |
| 0.031 | 0.021 | 0.031 | Acetylcholine M4 receptor agonist | |||
| 0.029 | 0.019 | 0.029 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.028 | 0.019 | 0.04 | Estrogen-related receptor gamma antagonist | 0.04 0.005 CID_6386 | CID_6386 | |
| 0.151 | 0.142 | 0.151 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.148 0.145 CID_6386 | ||
| 0.037 | 0.028 | 0.052 | Farnesoid X receptor agonist | 0.052 0.013 CID_6386 | CID_6386 | |
| 0.015 | 0.006 | 0.015 | Carbonic anhydrase XI inhibitor | 0.013 0.008 CID_6386 | ||
| 0.089 | 0.08 | 0.093 | Nitric-oxide synthase inhibitor | 0.093 0.073 CID_6386 | CID_6386 | |
| 0.027 | 0.018 | 0.027 | Toll-Like receptor 4 agonist | |||
| 0.031 | 0.023 | 0.065 | ATP citrate lysase inhibitor | 0.065 0.005 CID_6386 | CID_6386 | |
| 0.037 | 0.028 | 0.053 | Retinoid X receptor antagonist | 0.053 0.01 CID_6386 | CID_6386 | |
| 0.03 | 0.022 | 0.046 | Lysophosphatidic acid 2 receptor antagonist | 0.046 0.01 CID_6386 | CID_6386 | |
| 0.036 | 0.028 | 0.036 | Diamine oxidase inhibitor | 0.033 0.032 CID_6386 | ||
| 0.118 | 0.111 | 0.132 | Acetylcholine M1 receptor antagonist | 0.132 0.093 CID_6386 | CID_6386 | |
| 0.066 | 0.059 | 0.066 | Epoxide hydrolase inhibitor | |||
| 0.021 | 0.014 | 0.03 | Retinoid X beta receptor antagonist | 0.03 0.004 CID_6386 | CID_6386 | |
| 0.056 | 0.049 | 0.056 | TRPA1 antagonist | |||
| 0.025 | 0.018 | 0.025 | Acid ceramidase inhibitor | |||
| 0.026 | 0.019 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 CID_6386 | CID_6386 | |
| 0.054 | 0.047 | 0.063 | Leukotriene C antagonist | 0.063 0.022 CID_6386 | CID_6386 | |
| 0.033 | 0.026 | 0.046 | Retinoid X alpha receptor antagonist | 0.046 0.009 CID_6386 | CID_6386 | |
| 0.152 | 0.145 | 0.152 | Antiamyloidogenic | |||
| 0.014 | 0.008 | 0.014 | Cyclin D2 inhibitor | |||
| 0.05 | 0.044 | 0.058 | Leukotriene B4 antagonist | 0.058 0.031 CID_6386 | CID_6386 | |
| 0.03 | 0.024 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.032 0.022 CID_6386 | CID_6386 | |
| 0.039 | 0.033 | 0.053 | Oxytocin agonist | 0.053 0.022 CID_6386 | CID_6386 | |
| 0.087 | 0.082 | 0.108 | Urease inhibitor | 0.108 0.058 CID_6386 | CID_6386 | |
| 0.05 | 0.045 | 0.063 | Carbonic anhydrase VB inhibitor | 0.063 0.033 CID_6386 | CID_6386 | |
| 0.041 | 0.036 | 0.043 | Histamine H1 receptor agonist | 0.043 0.031 CID_6386 | CID_6386 | |
| 0.042 | 0.037 | 0.042 | Carbonic anhydrase VII inhibitor | |||
| 0.051 | 0.046 | 0.075 | Glucosylceramidase inhibitor | 0.075 0.019 CID_6386 | CID_6386 | |
| 0.052 | 0.048 | 0.052 | Cathepsin L inhibitor | |||
| 0.037 | 0.033 | 0.058 | CDK5/p25 inhibitor | 0.058 0.016 CID_6386 | CID_6386 | |
| 0.081 | 0.077 | 0.081 | ATPase (Vacuolar H+) inhibitor | |||
| 0.013 | 0.009 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.016 0.006 CID_6386 | CID_6386 | |
| 0.053 | 0.05 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | 0.063 0.033 CID_6386 | CID_6386 | |
| 0.03 | 0.027 | 0.039 | Peroxisome proliferator-activated receptor delta agonist | 0.039 0.017 CID_6386 | CID_6386 | |
| 0.016 | 0.013 | 0.024 | Vitamin D receptor agonist | 0.024 0.005 CID_6386 | CID_6386 | |
| 0.205 | 0.202 | 0.232 | Antiobesity | 0.232 0.174 CID_6386 | CID_6386 | |
| 0.013 | 0.01 | 0.013 | Angiotensin AT1B receptor antagonist | |||
| 0.056 | 0.053 | 0.056 | Protease activated receptor antagonist | |||
| 0.019 | 0.017 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.028 | 0.026 | 0.028 | Potassium channel small-conductance Ca-activated activator | |||
| 0.065 | 0.063 | 0.065 | Acetylcholine M4 receptor antagonist | |||
| 0.02 | 0.018 | 0.02 | Protease (Human cytomegalovirus) inhibitor | 0.02 0.018 CID_6386 | ||
| 0.038 | 0.036 | 0.057 | Sphingosine kinase 1 inhibitor | 0.057 0.011 CID_6386 | CID_6386 | |
| 0.035 | 0.034 | 0.042 | Dihydropteroate synthase inhibitor | 0.042 0.025 CID_6386 | CID_6386 | |
| 0.092 | 0.091 | 0.143 | Adenylate cyclase inhibitor | 0.143 0.05 CID_6386 | CID_6386 | |
| 0.014 | 0.013 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 CID_6386 | CID_6386 | |
| 0.041 | 0.041 | 0.064 | Glutamate (mGluR5) agonist | 0.064 0.016 CID_6386 | CID_6386 | |
| 0.014 | 0.014 | 0.02 | Thromboxane A2 agonist | 0.02 0.006 CID_6386 | CID_6386 | |
| 0.047 | 0.046 | 0.047 | Glucose-6-phosphate translocase inhibitor | |||
| 0.017 | 0.017 | 0.02 | Peroxisome proliferator-activated receptor alpha antagonist | 0.02 0.015 CID_6386 | CID_6386 | |
| 0.035 | 0.035 | 0.045 | MAP3K5 inhibitor | 0.045 0.018 CID_6386 | CID_6386 | |
| 0.03 | 0.03 | 0.061 | Retinoid X alpha receptor agonist | 0.061 0.011 CID_6386 | CID_6386 | |
| 0.084 | 0.084 | 0.113 | Xanthine oxidase inhibitor | 0.113 0.051 CID_6386 | CID_6386 | |
| 0.019 | 0.02 | 0.038 | Glutamate (mGluR1a) agonist | 0.038 0.006 CID_6386 | CID_6386 | |
| 0.034 | 0.034 | 0.037 | Delayed rectifier potassium channel blocker | 0.037 0.027 CID_6386 | CID_6386 | |
| 0.04 | 0.041 | 0.043 | Heme oxygenase inhibitor | 0.043 0.028 CID_6386 | CID_6386 | |
| 0.037 | 0.038 | 0.042 | CF transmembrane conductance regulator antagonist | 0.042 0.019 CID_6386 | CID_6386 | |
| 0.048 | 0.05 | 0.053 | Heparanase inhibitor | 0.053 0.038 CID_6386 | CID_6386 | |
| 0.089 | 0.091 | 0.152 | Folate antagonist | 0.152 0.021 CID_6386 | CID_6386 | |
| 0.048 | 0.05 | 0.055 | Lysine-specific demethylase 1A inhibitor | 0.055 0.035 CID_6386 | CID_6386 | |
| 0.003 | 0.005 | 0.006 | Glucokinase regulatory protein inhibitor | 0.006 0.003 CID_6386 | CID_6386 | |
| 0.013 | 0.016 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.012 CID_6386 | CID_6386 | |
| 0.051 | 0.054 | 0.057 | Botulinum neurotoxin type A inhibitor | 0.057 0.042 CID_6386 | CID_6386 | |
| 0.123 | 0.126 | 0.139 | MAP kinase 3 inhibitor | 0.139 0.086 CID_6386 | CID_6386 | |
| 0.05 | 0.052 | 0.054 | Fatty acid synthase inhibitor | 0.054 0.044 CID_6386 | CID_6386 | |
| 0.012 | 0.015 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 CID_6386 | CID_6386 | |
| 0.04 | 0.043 | 0.072 | Glutamate (mGluR group I) agonist | 0.072 0.015 CID_6386 | CID_6386 | |
| 0.117 | 0.12 | 0.143 | Hemostatic | 0.143 0.076 CID_6386 | CID_6386 | |
| 0.009 | 0.014 | 0.018 | Glutamate (mGluR6) agonist | 0.018 0.005 CID_6386 | CID_6386 | |
| 0.048 | 0.053 | 0.054 | Thromboxane synthase inhibitor | 0.054 0.038 CID_6386 | CID_6386 | |
| 0.049 | 0.055 | 0.094 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.094 0.019 CID_6386 | CID_6386 | |
| 0.018 | 0.024 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 CID_6386 | CID_6386 | |
| 0.055 | 0.061 | 0.058 | Matrix metalloproteinase inhibitor | 0.058 0.057 CID_6386 | CID_6386 | |
| 0.016 | 0.022 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.012 CID_6386 | CID_6386 | |
| 0.019 | 0.025 | 0.06 | Vitamin D receptor antagonist | 0.06 0.004 CID_6386 | CID_6386 | |
| 0.003 | 0.01 | 0.005 | Transcortin receptor antagonist | 0.005 0.004 CID_6386 | CID_6386 | |
| 0.037 | 0.045 | 0.053 | Dihydroorotase inhibitor | 0.053 0.022 CID_6386 | CID_6386 | |
| 0.094 | 0.102 | 0.105 | MAP kinase kinase inhibitor | 0.105 0.089 CID_6386 | CID_6386 | |
| 0.083 | 0.09 | 0.092 | Mediator release inhibitor | 0.092 0.08 CID_6386 | CID_6386 | |
| 0.069 | 0.076 | 0.077 | Sphingosine 1-phosphate receptor antagonist | 0.077 0.052 CID_6386 | CID_6386 | |
| 0.023 | 0.031 | 0.048 | Squalene synthetase inhibitor | 0.048 0.015 CID_6386 | CID_6386 | |
| 0.027 | 0.036 | 0.042 | Free fatty acid receptor 1 antagonist | 0.042 0.014 CID_6386 | CID_6386 | |
| 0.025 | 0.035 | 0.035 | Calcitonin receptor agonist | 0.035 0.023 CID_6386 | CID_6386 | |
| 0.014 | 0.024 | 0.018 | CXC chemokine 5 receptor antagonist | 0.018 0.012 CID_6386 | CID_6386 | |
| 0.055 | 0.065 | 0.065 | Beta adrenoreceptor antagonist | 0.065 0.046 CID_6386 | CID_6386 | |
| 0.029 | 0.039 | 0.033 | Delayed rectifier potassium channel activator | 0.033 0.03 CID_6386 | CID_6386 | |
| 0.029 | 0.039 | 0.033 | Potassium channel KCNQ activator | 0.033 0.03 CID_6386 | CID_6386 | |
| 0.005 | 0.015 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 CID_6386 | CID_6386 | |
| 0.056 | 0.067 | 0.064 | Carbonic anhydrase VA inhibitor | 0.064 0.053 CID_6386 | CID_6386 | |
| 0.053 | 0.064 | 0.091 | Sphingosine 1-phosphate receptor 4 agonist | 0.091 0.03 CID_6386 | CID_6386 | |
| 0.056 | 0.068 | 0.066 | Beta 3 adrenoreceptor antagonist | 0.066 0.04 CID_6386 | CID_6386 | |
| 0.028 | 0.039 | 0.035 | Carboxypeptidase B inhibitor | 0.035 0.02 CID_6386 | CID_6386 | |
| 0.034 | 0.046 | 0.042 | Leukotriene C4 antagonist | 0.042 0.02 CID_6386 | CID_6386 | |
| 0.024 | 0.037 | 0.048 | Progesterone antagonist | 0.048 0.019 CID_6386 | CID_6386 | |
| 0.019 | 0.031 | 0.023 | ICAM 1 antagonist | 0.023 0.016 CID_6386 | CID_6386 | |
| 0.052 | 0.064 | 0.068 | Leukotriene antagonist | 0.068 0.042 CID_6386 | CID_6386 | |
| 0.085 | 0.098 | 0.094 | Beta glucuronidase inhibitor | 0.094 0.079 CID_6386 | CID_6386 | |
| 0.029 | 0.042 | 0.049 | Glutamate (mGluR3) antagonist | 0.049 0.013 CID_6386 | CID_6386 | |
| 0.076 | 0.089 | 0.129 | Alcohol dehydrogenase inhibitor | 0.129 0.029 CID_6386 | CID_6386 | |
| 0.016 | 0.03 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | 0.02 0.018 CID_6386 | CID_6386 | |
| 0.044 | 0.057 | 0.056 | Beta 1 adrenoreceptor antagonist | 0.056 0.04 CID_6386 | CID_6386 | |
| 0.079 | 0.095 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | 0.092 0.068 CID_6386 | CID_6386 | |
| 0.03 | 0.046 | 0.04 | Vascular adhesion protein 1 inhibitor | 0.04 0.025 CID_6386 | CID_6386 | |
| 0.001 | 0.017 | 0.005 | Vitamin D-like | 0.005 0.002 CID_6386 | CID_6386 | |
| 0.026 | 0.042 | 0.045 | Nicotinic acid receptor agonist | 0.045 0.017 CID_6386 | CID_6386 | |
| 0.038 | 0.055 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.034 CID_6386 | CID_6386 | |
| 0.032 | 0.049 | 0.044 | Phosphorylase inhibitor | 0.044 0.034 CID_6386 | CID_6386 | |
| 0.04 | 0.057 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 CID_6386 | CID_6386 | |
| 0.028 | 0.045 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.026 CID_6386 | CID_6386 | |
| 0.013 | 0.031 | 0.019 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 CID_6386 | CID_6386 | |
| 0.055 | 0.074 | 0.065 | Beta 2 adrenoreceptor agonist | 0.065 0.031 CID_6386 | CID_6386 | |
| 0.006 | 0.024 | 0.01 | Thromboxane agonist | 0.01 0.008 CID_6386 | CID_6386 | |
| 0.048 | 0.067 | 0.058 | Neutrophil collagenase inhibitor | 0.058 0.053 CID_6386 | CID_6386 | |
| 0.087 | 0.107 | 0.1 | Acetylcholine muscarinic antagonist | 0.1 0.091 CID_6386 | CID_6386 | |
| 0.021 | 0.04 | 0.029 | Thymidine phosphorylase inhibitor | 0.029 0.013 CID_6386 | CID_6386 | |
| 0.011 | 0.031 | 0.024 | Nicotinic acid receptor 1 antagonist | 0.024 0.006 CID_6386 | CID_6386 | |
| 0.05 | 0.069 | 0.059 | Carbonic anhydrase V inhibitor | 0.059 0.055 CID_6386 | CID_6386 | |
| 0.018 | 0.038 | 0.072 | Glucocorticoid antagonist | 0.072 0.008 CID_6386 | CID_6386 | |
| 0.1 | 0.121 | 0.108 | Toll-Like receptor antagonist | 0.108 0.106 CID_6386 | CID_6386 | |
| 0.038 | 0.059 | 0.06 | Diacylglycerol O-acyltransferase inhibitor | 0.06 0.026 CID_6386 | CID_6386 | |
| 0.012 | 0.033 | 0.039 | Prostaglandin EP2 agonist | 0.039 0.009 CID_6386 | CID_6386 | |
| 0.105 | 0.126 | 0.134 | Diuretic | 0.134 0.091 CID_6386 | CID_6386 | |
| 0.06 | 0.082 | 0.066 | Metalloproteinase-9 inhibitor | 0.066 0.065 CID_6386 | CID_6386 | |
| 0.039 | 0.061 | 0.056 | Toll-Like receptor 8 antagonist | 0.056 0.035 CID_6386 | CID_6386 | |
| 0.046 | 0.069 | 0.054 | Sphingosine 1-phosphate receptor 1 antagonist | 0.054 0.041 CID_6386 | CID_6386 | |
| 0.009 | 0.032 | 0.016 | Aminopeptidase A inhibitor | 0.016 0.014 CID_6386 | CID_6386 | |
| 0.019 | 0.042 | 0.025 | Thyroid hormone agonist | 0.025 0.019 CID_6386 | CID_6386 | |
| 0.035 | 0.058 | 0.049 | Glutamate (mGluR4) antagonist | 0.049 0.021 CID_6386 | CID_6386 | |
| 0.013 | 0.037 | 0.027 | Prostaglandin H2 antagonist | 0.027 0.016 CID_6386 | CID_6386 | |
| 0.006 | 0.03 | 0.018 | Prostaglandin EP4 agonist | 0.018 0.009 CID_6386 | CID_6386 | |
| 0.027 | 0.051 | 0.036 | Urate transporter 1 inhibitor | 0.036 0.031 CID_6386 | CID_6386 | |
| 0.096 | 0.121 | 0.118 | Transcription factor STAT6 inhibitor | 0.118 0.064 CID_6386 | CID_6386 | |
| 0.088 | 0.113 | 0.103 | Nav1.3 sodium channel blocker | 0.103 0.094 CID_6386 | CID_6386 | |
| 0.019 | 0.044 | 0.035 | LFA antagonist | 0.035 0.01 CID_6386 | CID_6386 | |
| 0.017 | 0.042 | 0.032 | Lysine carboxypeptidase inhibitor | 0.032 0.014 CID_6386 | CID_6386 | |
| 0.029 | 0.054 | 0.039 | Tryptophan 5 hydroxylase inhibitor | 0.039 0.017 CID_6386 | CID_6386 | |
| 0.022 | 0.048 | 0.036 | 5-Alpha-reductase inhibitor | 0.036 0.027 CID_6386 | CID_6386 | |
| 0.013 | 0.039 | 0.025 | Prostaglandin E2 agonist | 0.025 0.014 CID_6386 | CID_6386 | |
| 0.026 | 0.052 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 CID_6386 | CID_6386 | |
| 0.031 | 0.057 | 0.045 | Antimetabolite | 0.045 0.035 CID_6386 | CID_6386 | |
| 0.063 | 0.09 | 0.085 | Estrogen receptor alpha antagonist | 0.085 0.041 CID_6386 | CID_6386 | |
| 0.014 | 0.041 | 0.018 | Caspase 8 inhibitor | 0.018 0.016 CID_6386 | CID_6386 | |
| 0.162 | 0.191 | 0.189 | 12-Lipoxygenase inhibitor | 0.189 0.163 CID_6386 | CID_6386 | |
| 0.071 | 0.106 | 0.085 | Vanilloid agonist | 0.085 0.058 CID_6386 | CID_6386 | |
| 0.062 | 0.1 | 0.091 | Potassium channel (Ca-activated) activator | 0.091 0.064 CID_6386 | CID_6386 | |
| 0.012 | 0.05 | 0.022 | CC chemokine 1 receptor antagonist | 0.022 0.018 CID_6386 | CID_6386 | |
| 0.105 | 0.143 | 0.18 | Farnesoid X receptor antagonist | 0.18 0.029 CID_6386 | CID_6386 | |
| 0.005 | 0.044 | 0.011 | Immunosuppressant Cyclosporine-like | 0.011 0.009 CID_6386 | CID_6386 | |
| 0.028 | 0.067 | 0.047 | AMPA 4 receptor antagonist | 0.047 0.018 CID_6386 | CID_6386 | |
| 0.012 | 0.054 | 0.022 | Progesterone receptor B antagonist | 0.022 0.009 CID_6386 | CID_6386 | |
| 0.022 | 0.067 | 0.046 | Peroxisome proliferator-activated receptor delta antagonist | 0.046 0.011 CID_6386 | CID_6386 | |
| 0.045 | 0.09 | 0.173 | Cyclin B3 inhibitor | 0.173 0.009 CID_6386 | CID_6386 | |
| 0.015 | 0.064 | 0.04 | Kainate receptor 2 antagonist | 0.04 0.022 CID_6386 | CID_6386 | |
| 0.108 | 0.164 | 0.16 | Pyruvate kinase inhibitor | 0.16 0.107 CID_6386 | CID_6386 | |
| 0.035 | 0.093 | 0.043 | Beta adrenoreceptor agonist | 0.043 0.041 CID_6386 | CID_6386 | |
| 0.023 | 0.082 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | 0.048 0.042 CID_6386 | CID_6386 | |
| 0.023 | 0.082 | 0.049 | Ribonucleotide reductase inhibitor | 0.049 0.043 CID_6386 | CID_6386 | |
| 0.099 | 0.16 | 0.14 | Cyclin-dependent kinase 8 inhibitor | 0.14 0.09 CID_6386 | CID_6386 | |
| 0.024 | 0.087 | 0.048 | Thymidylate synthase inhibitor | 0.048 0.03 CID_6386 | CID_6386 | |
| 0.022 | 0.087 | 0.038 | Sphingosine 1-phosphate receptor 1 agonist | 0.038 0.036 CID_6386 | CID_6386 | |
| 0.004 | 0.075 | 0.053 | Glucocorticoid agonist | 0.053 0.004 CID_6386 | CID_6386 | |
| 0.039 | 0.114 | 0.098 | Glutamate receptor agonist | 0.098 0.039 CID_6386 | CID_6386 | |
| 0.066 | 0.145 | 0.097 | DNA polymerase I inhibitor | 0.097 0.089 CID_6386 | CID_6386 | |
| 0.027 | 0.108 | 0.057 | NMDA 2C receptor antagonist | 0.057 0.049 CID_6386 | CID_6386 | |
| 0.023 | 0.111 | 0.058 | Phosphodiesterase 2A inhibitor | 0.058 0.025 CID_6386 | CID_6386 | |
| 0.046 | 0.138 | 0.072 | Adrenaline agonist | 0.072 0.069 CID_6386 | CID_6386 | |
| 0.023 | 0.115 | 0.066 | Phosphodiesterase II inhibitor | 0.066 0.026 CID_6386 | CID_6386 | |
| 0.103 | 0.199 | 0.144 | Anticonvulsant | 0.144 0.137 CID_6386 | CID_6386 | |
| 0.156 | 0.257 | 0.321 | Sodium/bile acid cotransporter inhibitor | 0.321 0.061 CID_6386 | CID_6386 | |
| 0.011 | 0.114 | 0.04 | Prostaglandin D2 agonist | 0.04 0.013 CID_6386 | CID_6386 | |
| 0.016 | 0.126 | 0.106 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.106 0.01 CID_6386 | CID_6386 | |
| 0.018 | 0.13 | 0.054 | p53 inhibitor | 0.054 0.012 CID_6386 | CID_6386 | |
| 0.063 | 0.176 | 0.156 | Bone formation stimulant | 0.156 0.054 CID_6386 | CID_6386 | |
| 0.027 | 0.146 | 0.059 | Cyclin B1 inhibitor | 0.059 0.045 CID_6386 | CID_6386 | |
| 0.021 | 0.142 | 0.056 | Cyclin B2 inhibitor | 0.056 0.037 CID_6386 | CID_6386 | |
| 0.012 | 0.14 | 0.037 | HMG CoA reductase inhibitor | 0.037 0.018 CID_6386 | CID_6386 | |
| 0.019 | 0.165 | 0.063 | Neuraminidase (Influenza A) inhibitor | 0.063 0.01 CID_6386 | CID_6386 | |
| 0.063 | 0.231 | 0.113 | Interleukin 4 antagonist | 0.113 0.096 CID_6386 | CID_6386 | |
| 0.072 | 0.244 | 0.229 | Aurora-C kinase inhibitor | 0.229 0.013 CID_6386 | CID_6386 | |
| 0.008 | 0.23 | 0.027 | Retinoid X gamma receptor antagonist | 0.027 0.018 CID_6386 | CID_6386 | |
| 0.027 | 0.249 | 0.052 | Factor III inhibitor | 0.052 0.03 CID_6386 | CID_6386 | |
| 0.012 | 0.275 | 0.036 | Retinoic acid alpha receptor agonist | 0.036 0.033 CID_6386 | CID_6386 | |
| 0.105 | 0.371 | 0.202 | Toll-Like receptor agonist | 0.202 0.2 CID_6386 | CID_6386 | |
| 0.132 | 0.467 | 0.243 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.243 0.075 CID_6386 | CID_6386 | |
| 0.018 | 0.373 | 0.062 | Cyclin H inhibitor | 0.062 0.037 CID_6386 | CID_6386 | |
| 0.096 | 0.458 | 0.253 | Peptidyltransferase inhibitor | 0.253 0.049 CID_6386 | CID_6386 | |
| 0.057 | 0.421 | 0.129 | Growth hormone agonist | 0.129 0.109 CID_6386 | CID_6386 | |
| 0.022 | 0.472 | 0.125 | Thrombolytic | 0.125 0.105 CID_6386 | CID_6386 | |
| 0.036 | 0.929 | 0.238 | Interleukin 2 agonist | 0.238 0.133 CID_6386 | CID_6386 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |